Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Itamar Raz

Showing results (141-150 of 254) with videos related to

Pageof 26
Sort By:
Diabetes|April 28, 2005
Nonproteinuric diabetes-associated nephropathy in the Cohen rat model of type 2 diabetesChana Yagil, Adiel Barak, David Ben-Dor, et al.
Diabetes Care|May 20, 2011
Post hoc subgroup analysis of the HEART2D trial demonstrates lower cardiovascular risk in older patients targeting postprandial versus fasting/premeal glycemiaItamar Raz, Antonio Ceriello, Peter W Wilson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 6, 2020
Safety of Liraglutide in Type 2 Diabetes and Chronic Kidney DiseaseJohannes F E Mann, Vivian A Fonseca, Neil R Poulter, et al.
Diabetes Care|August 24, 2017
Influences of Breakfast on Clock Gene Expression and Postprandial Glycemia in Healthy Individuals and Individuals With Diabetes: A Randomized Clinical TrialDaniela Jakubowicz, Julio Wainstein, Zohar Landau, et al.
European Heart Journal|February 3, 2018
Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular riskBrian A Bergmark, Benjamin M Scirica, Ph Gabriel Steg, et al.
Plos One|June 21, 2022
Bilirubin levels and kidney function decline: An analysis of clinical trial and real world dataYasunori Aoki, Claudia S Cabrera, Mario Ouwens, et al.
Diabetes Research and Clinical Practice|December 14, 2020
Management of patients with diabetes and obesity in the COVID-19 era: Experiences and learnings from South and East Europe, the Middle East, and AfricaFrancesco Giorgino, Sindeep Bhana, Leszek Czupryniak, et al.
Diabetes Care|August 23, 2014
Beyond metformin: safety considerations in the decision-making process for selecting a second medication for type 2 diabetes management: reflections from a diabetes care editors' expert forumWilliam T Cefalu, John B Buse, Stefano Del Prato, et al.
Diabetes|November 6, 2007
Impaired glucose-stimulated insulin secretion is coupled with exocrine pancreatic lesions in the Cohen diabetic ratSarah Weksler-Zangen, Itamar Raz, Sigurd Lenzen, et al.
Diabetes Care|January 24, 2013
The efficacy and safety of insulin degludec given in variable once-daily dosing intervals compared with insulin glargine and insulin degludec dosed at the same time daily: a 26-week, randomized, open-label, parallel-group, treat-to-target trial in individuals with type 2 diabetesLuigi Meneghini, Stephen L Atkin, Stephen C L Gough, et al.
Pageof 26

Showing results (141-150 of 254) with videos related to

Sort By:
Pageof 26
Diabetes|April 28, 2005
Nonproteinuric diabetes-associated nephropathy in the Cohen rat model of type 2 diabetesChana Yagil, Adiel Barak, David Ben-Dor, et al.
Diabetes Care|May 20, 2011
Post hoc subgroup analysis of the HEART2D trial demonstrates lower cardiovascular risk in older patients targeting postprandial versus fasting/premeal glycemiaItamar Raz, Antonio Ceriello, Peter W Wilson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 6, 2020
Safety of Liraglutide in Type 2 Diabetes and Chronic Kidney DiseaseJohannes F E Mann, Vivian A Fonseca, Neil R Poulter, et al.
Diabetes Care|August 24, 2017
Influences of Breakfast on Clock Gene Expression and Postprandial Glycemia in Healthy Individuals and Individuals With Diabetes: A Randomized Clinical TrialDaniela Jakubowicz, Julio Wainstein, Zohar Landau, et al.
European Heart Journal|February 3, 2018
Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular riskBrian A Bergmark, Benjamin M Scirica, Ph Gabriel Steg, et al.
Plos One|June 21, 2022
Bilirubin levels and kidney function decline: An analysis of clinical trial and real world dataYasunori Aoki, Claudia S Cabrera, Mario Ouwens, et al.
Diabetes Research and Clinical Practice|December 14, 2020
Management of patients with diabetes and obesity in the COVID-19 era: Experiences and learnings from South and East Europe, the Middle East, and AfricaFrancesco Giorgino, Sindeep Bhana, Leszek Czupryniak, et al.
Diabetes Care|August 23, 2014
Beyond metformin: safety considerations in the decision-making process for selecting a second medication for type 2 diabetes management: reflections from a diabetes care editors' expert forumWilliam T Cefalu, John B Buse, Stefano Del Prato, et al.
Diabetes|November 6, 2007
Impaired glucose-stimulated insulin secretion is coupled with exocrine pancreatic lesions in the Cohen diabetic ratSarah Weksler-Zangen, Itamar Raz, Sigurd Lenzen, et al.
Diabetes Care|January 24, 2013
The efficacy and safety of insulin degludec given in variable once-daily dosing intervals compared with insulin glargine and insulin degludec dosed at the same time daily: a 26-week, randomized, open-label, parallel-group, treat-to-target trial in individuals with type 2 diabetesLuigi Meneghini, Stephen L Atkin, Stephen C L Gough, et al.
Pageof 26